Proteocyte AI

Proteocyte AI is a Canadian molecular diagnostics company that has developed a groundbreaking technology called Straticyte™. This innovative diagnostic tool accurately determines the risk of a head and neck lesion developing into cancer in the near future. By identifying high-risk lesions, clinicians can provide early interventions, leading to improved clinical outcomes and a better quality of life for individuals with head and neck cancer. Additionally, Straticyte™ allows for effective follow-up and management of moderate and low-risk lesions. Proteocyte AI's advanced diagnostic technology is set to revolutionize cancer diagnostics and significantly enhance patient care.